Regulatory pathway, reimbursement, IP, and go-to-market are not four separate problems to hand to four separate vendors. They are one decision, and getting the order wrong costs you a year. I have made that decision before, from inside the company and from the outside.
Book a 30-minute callMost of my clients are one to fifty people. They have non-dilutive funding or a seed round, a working prototype, deep technical talent, and nobody whose job is getting the thing sold.
That is a solvable problem, and it is almost always solved in the wrong order. Companies lock a regulatory pathway before they know who pays, or build a sales model around a billing code that does not exist yet. The sequence is the strategy.
Fixed fee, scoped up front, priced in public. You will know what it costs before you get on the phone with me.
$18,000 – $25,000
Fixed fee · 3 weeks
One document that sequences regulatory pathway, reimbursement strategy, IP position, and first-market entry into a single plan with dates and owners.
Doubles as the commercialization plan an SBIR Phase II application requires.
$10,000 – $16,000/mo
2 days per week · 3-month minimum
Senior commercial leadership on your team without the search, the equity, or the fully loaded cost of a full-time executive.
Most engagements run three to nine months and end with a hire.
$25,000 – $40,000
Fixed fee · 4 to 6 weeks
I install the AI workflows I run my own practice on inside your company, and train your team to keep them running after I leave.
For teams who keep hearing they should use AI and have never been shown how.
Fixed fee, never hourly. Hourly billing penalizes speed, and speed is the thing I am actually selling.
| Company | Years | What I did |
|---|---|---|
| Smart Human Dynamics | 2014 – 2026 | Founder and CEO. AI-enabled remote patient monitoring and wearables. Mayo Clinic partnership and investment, NIH SBIR with the University of Michigan, IRB clinical trials, four issued patents. |
| Bespoke Innovations / 3D Systems | 2012 – 2014 | Senior Director, Marketing and Business Development. Built a national direct and distributor channel from zero. |
| Spiracur | 2009 – 2012 | Wound care. Office-based go-to-market built on reimbursement codes that already existed, which is the fastest revenue path a device company ever gets. |
| Guidant → Abbott | 2001 – 2006 | Endovascular and vascular intervention, then the bioabsorbable stent program that carried into Abbott. |
| Advisory | Selected | Materna, Volcano, Abbott, Amaranth, Innospine, Luma, HX Diagnostics. |
I have been the founder writing the SBIR application, the executive presenting to the board, and the marketer standing in an operating room at six in the morning. I have raised money, run trials, prosecuted patents, and closed first customers.
I am also unusually far along with AI tooling, and do the majority of my work through it now. That is why I can sell fixed-fee engagements at speeds that used to require a team. It is a delivery advantage, not a product pitch. I am a commercialization operator who happens to be AI-native.
Based in Lafayette, California. Bay Area companies in person, everyone else remotely.
Thirty minutes, no charge, no deck. Bring your situation and I will tell you what I would do first, whether or not you hire me.